BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28682064)

  • 1. A Very Rare Example of a Structurally Characterized 3'-GMP Metal Complex. NMR and Synthetic Assessment of Adducts Formed by Guanine Derivatives with [Pt(L
    Ranasinghe K; Pakhomova S; Marzilli PA; Marzilli LG
    Inorg Chem; 2017 Jul; 56(14):8462-8477. PubMed ID: 28682064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guanine nucleobase adducts formed by [Pt(di-(2-picolyl)amine)Cl]Cl: evidence that a tridentate ligand with only in-plane bulk can slow guanine base rotation.
    Andrepont C; Marzilli PA; Marzilli LG
    Inorg Chem; 2012 Nov; 51(21):11961-70. PubMed ID: 23094695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guanine nucleobase adducts formed by a monofunctional complex: [Pt(N-(6-methyl-2-picolyl)-N-(2-picolyl)amine)Cl]Cl.
    Andrepont C; Marzilli PA; Pakhomova S; Marzilli LG
    J Inorg Biochem; 2015 Dec; 153():219-230. PubMed ID: 26239547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unusual Example of Chelate Ring Opening upon Coordination of the 9-Ethylguanine Nucleobase to [Pt(di-(6-methyl-2-picolyl)amine)Cl]Cl.
    Andrepont C; Pakhomova S; Marzilli PA; Marzilli LG
    Inorg Chem; 2015 May; 54(10):4895-908. PubMed ID: 25910178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation relevant to the conformation of the 17-membered Pt(d(GpG)) macrocyclic ring formed by Pt anticancer drugs with DNA: Pt complexes with a Goldilocks carrier ligand.
    Maheshwari V; Marzilli PA; Marzilli LG
    Inorg Chem; 2011 Jul; 50(14):6626-36. PubMed ID: 21667929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel binding interactions of the DNA fragment d(pGpG) cross-linked by the antitumor active compound tetrakis(mu-carboxylato)dirhodium(II,II).
    Chifotides HT; Koshlap KM; Pérez LM; Dunbar KR
    J Am Chem Soc; 2003 Sep; 125(35):10714-24. PubMed ID: 12940757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of carrier ligand NH hydrogen bonding to the O6 and phosphate group of guanine nucleotides in platinum complexes with a single guanine ligand.
    Carlone M; Fanizzi FP; Intini FP; Margiotta N; Marzilli LG; Natile G
    Inorg Chem; 2000 Feb; 39(4):634-41. PubMed ID: 11272556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platinum complexes with NH groups on the carrier ligand and with only one guanine or hypoxanthine derivative. Informative models for assessing relative nucleobase and nucleotide hydrogen-bond interactions with amine ligands in solution.
    Carlone M; Marzilli LG; Natile G
    Inorg Chem; 2004 Jan; 43(2):584-92. PubMed ID: 14731020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neglected bidentate sp2 N-donor carrier ligands with triazine nitrogen lone pairs: platinum complexes retromodeling cisplatin guanine nucleobase adducts.
    Maheshwari V; Marzilli PA; Marzilli LG
    Inorg Chem; 2008 Oct; 47(20):9303-13. PubMed ID: 18800828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR studies of models having the Pt(d(GpG)) 17-membered macrocyclic ring formed in DNA by platinum anticancer drugs: Pt complexes with bulky chiral diamine ligands.
    Saad JS; Benedetti M; Natile G; Marzilli LG
    Inorg Chem; 2011 May; 50(10):4559-71. PubMed ID: 21510625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rotamer stability in cis-[Pt(diA)G2] complexes (diA = diamine derivative and G = guanine derivative) mediated by carrier-ligand amine stereochemistry as revealed by circular dichroism spectroscopy.
    Benedetti M; Marzilli LG; Natile G
    Chemistry; 2005 Sep; 11(18):5302-10. PubMed ID: 15997435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diminishing Dynamic Motion Problems of Platinum Anticancer Drug Adducts of Guanine Derivatives with the Hybrid Ligand Approach: Evidence for Cis Interligand Interactions Especially between 3'-GMP's.
    Wong HC; Intini FP; Natile G; Marzilli LG
    Inorg Chem; 1999 Mar; 38(5):1006-1014. PubMed ID: 11670875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing conformer equilibria in retro models of cisplatin-DNA adducts as revealed by moderately dynamic (N,N'-dimethyl-2,3-diaminobutane)PtG(2) retro models (G = a guanine derivative).
    Saad JS; Scarcia T; Natile G; Marzilli LG
    Inorg Chem; 2002 Sep; 41(19):4923-35. PubMed ID: 12230397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes.
    Choi S; Vastag L; Larrabee YC; Personick ML; Schaberg KB; Fowler BJ; Sandwick RK; Rawji G
    Inorg Chem; 2008 Feb; 47(4):1352-60. PubMed ID: 18220340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basic coordination chemistry relevant to DNA adducts formed by the cisplatin anticancer drug. NMR studies on compounds with sterically crowded chiral ligands.
    Saad JS; Benedetti M; Natile G; Marzilli LG
    Inorg Chem; 2010 Jun; 49(12):5573-83. PubMed ID: 20496875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rare example of three abundant conformers in one retro model of the cisplatin-DNA d(GpG) intrastrand cross link. Unambiguous evidence that guanine O6 to carrier amine ligand hydrogen bonding is not important. possible effect of the Lippard base pair step adjacent to the lesion on carrier ligand hydrogen bonding in DNA adducts.
    Sullivan ST; Ciccarese A; Fanizzi FP; Marzilli LG
    J Am Chem Soc; 2001 Sep; 123(38):9345-55. PubMed ID: 11562217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-stranded oligonucleotide adducts formed by Pt complexes favoring left-handed base canting: steric effect of flanking residues and relevance to DNA adducts formed by Pt anticancer drugs.
    Saad JS; Marzilli PA; Intini FP; Natile G; Marzilli LG
    Inorg Chem; 2011 Sep; 50(17):8608-20. PubMed ID: 21819051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chirality-Controlling Chelate (CCC) Ligands in Analogues of Platinum Anticancer Agents. Influence of N9 Substituents of Guanine Derivatives (G) on the Distribution of Chiral Conformers of (CCC)PtG(2) with CCC = N,N'-Dimethyl-2,3-diaminobutane.
    Marzilli LG; Intini FP; Kiser D; Wong HC; Ano SO; Marzilli PA; Natile G
    Inorg Chem; 1998 Dec; 37(26):6898-6905. PubMed ID: 11670827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new anticancer drug [(2R)-aminomethylpyrrolidine](1, 1-cyclobutanedicarboxylato)platinum(II) and its toxic S enantiomer do interact differently with nucleic acids.
    Bloemink MJ; Pérez JM; Heetebrij RJ; Reedijk J
    J Biol Inorg Chem; 1999 Oct; 4(5):554-67. PubMed ID: 10550684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-ray structure and circular dichroism of pure rotamers of bis[guanosine-5'-monophosphate(-1)](N,N,N',N'-tetramethylcyclohexyl-1,2-diamine)platinum(II) complexes that have R,R and S,S configurations at the asymmetric diamine.
    Benedetti M; Tamasi G; Cini R; Natile G
    Chemistry; 2003 Dec; 9(24):6122-32. PubMed ID: 14679524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.